
ANI Pharmaceuticals (NASDAQ:ANIP) brought in sales totaling $60.93 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 442.75%, resulting in a loss of $24.14 million. In Q3, ANI Pharmaceuticals brought in $52.06 million in sales but lost $4.45 million in earnings.